| Summary of Segment Reporting |
The table below summarizes the significant expense categories regularly reviewed by the CODM for the six months ended June 30, 2026 and 2025 (amounts in thousands):
| | | | | | | | | | | | | | | | | |
| |
|
Three months ended
June 30
|
|
|
Six months ended
June 30
|
|
| |
|
2026
| |
|
2025
| |
|
2026
| |
|
2025
| |
|
Revenue
|
| $ | 1,969 | |
| $ | 1,725 | |
| $ | 4,372 | |
| $ | 3,629 | |
|
Gross Profit
|
| | 1,498 | |
| | 958 | |
| | 3,182 | |
| | 2,025 | |
|
Gross profit %
|
| | 76.1 | % |
| | 55.5 | % |
| | 72.8 | % |
| | 55.8 | % |
|
Operating expenses:
|
| | | |
| | | |
| | | |
| | | |
|
General and administrative
|
| | 1,524 | |
| | 1,347 | |
| | 3,633 | |
| | 3,189 | |
|
Sales and marketing
|
| | 1,984 | |
| | 1,598 | |
| | 4,066 | |
| | 3,028 | |
|
Development
|
| | 431 | |
| | 327 | |
| | 1,660 | |
| | 533 | |
|
Clinical, Quality, Regulatory
|
| | 706 | |
| | 575 | |
| | 1,513 | |
| | 1,157 | |
|
Total operating expenses
|
| | 4,645 | |
| | 3,847 | |
| | 10,872 | |
| | 7,907 | |
|
Stock Based Compensation
|
| | 22 | |
| | 17 | |
| | 47 | |
| | 84 | |
|
Other Expense
|
| | 1,659 | |
| | 9,647 | |
| | 1,632 | |
| | 9,601 | |
|
Net loss
|
| $ | (4,828 | ) |
| $ | (12,553 | ) |
| $ | (9,369 | ) |
| $ | (15,567 | ) |
|